Hemab Therapeutics Holdings, Inc. (COAG) at a glance

Hemab Therapeutics Holdings, Inc. (COAG) is a small-cap Healthcare company. It trades at $45.91, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 53/100 overall. Its strongest dimension is Safety (66/100) and its weakest is Income (40/100).

Price
$45.91
Market cap
$1.17B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$23.00 to $55.42
Vestovix Score53/ 100How this works
Value
50
Growth
50
Income
40
Safety
66
Momentum
65

Other Healthcare stocks

See all